Clinical trial
A Multicenter, Prospective, Real-World Observational Study to Evaluate the Efficacy and Safety of Jaktinib in Patients With Myelofibrosis and Ruxolitinib Treatment Failure
NCT07925671 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Real-World Observational Study to Evaluate the Efficacy and Safety of Jaktinib in Patients With Myelofibrosis and Ruxolitinib Treatment Failure
- Lead sponsor
- Affiliated Hospital of Nantong University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 10, 2026
- Completion date
- December 31, 2028
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myeloproliferative neoplasms/myelofibrosis
Lead sponsor's other trials
Affiliated Hospital of Nantong University, most recent start first.
+91 more trials See the organization page
Similar trials
Same condition (Primary Myelofibrosis) and phase, most recent start first.
+72 more trials See the condition page